NCT/Study#
NCT03209401 /
2017-0085
Niraparib Plus Carboplatin In Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies
DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
